Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients.
Cavalieri S, Orlandi E, Ivaldi E, Bergamini C, Alfieri S, Iacovelli NA, Ingargiola R, Resteghini C, Platini F, Apollonio G, Beninato T, Incandela F, Fontanella W, Bresciani L, Giannini L, Piazza C, Licitra L, Locati LD. Cavalieri S, et al. Among authors: bergamini c. Eur Arch Otorhinolaryngol. 2021 Mar;278(3):771-779. doi: 10.1007/s00405-020-06179-1. Epub 2020 Jul 12. Eur Arch Otorhinolaryngol. 2021. PMID: 32656672
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients.
Bossi P, Liberatoscioli C, Bergamini C, Locati LD, Fava S, Rinaldi G, Orlandi E, Olmi P, Tagliabue E, Ménard S, Licitra L. Bossi P, et al. Among authors: bergamini c. Ann Oncol. 2007 Mar;18(3):601-2. doi: 10.1093/annonc/mdl409. Epub 2006 Oct 30. Ann Oncol. 2007. PMID: 17074970 Free article. No abstract available.
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M, Tomatis S, Orlandi E, Guzzo M, Sangalli C, Potepan P, Fantini S, Bergamini C, Gavazzi C, Licitra L, Scaramellini G, Cantu' G, Olmi P. Palazzi M, et al. Among authors: bergamini c. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):330-7. doi: 10.1016/j.ijrobp.2007.06.022. Epub 2007 Sep 19. Int J Radiat Oncol Biol Phys. 2008. PMID: 17881148
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study.
Locati LD, Bossi P, Perrone F, Potepan P, Crippa F, Mariani L, Casieri P, Orsenigo M, Losa M, Bergamini C, Liberatoscioli C, Quattrone P, Calderone RG, Rinaldi G, Pilotti S, Licitra L. Locati LD, et al. Among authors: bergamini c. Oral Oncol. 2009 Jul;45(7):574-8. doi: 10.1016/j.oraloncology.2008.07.010. Epub 2008 Sep 18. Oral Oncol. 2009. PMID: 18804410 Clinical Trial.
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).
Locati LD, Perrone F, Losa M, Mela M, Casieri P, Orsenigo M, Cortelazzi B, Negri T, Tamborini E, Quattrone P, Bossi P, Rinaldi G, Bergamini C, Calderone RG, Liberatoscioli C, Licitra L. Locati LD, et al. Among authors: bergamini c. Oral Oncol. 2009 Nov;45(11):986-90. doi: 10.1016/j.oraloncology.2009.05.635. Epub 2009 Jul 1. Oral Oncol. 2009. PMID: 19574086
Comment on "Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis", by Rades et coll.
Bossi P, Granata R, Bergamini C, Mirabile A, Locati L, Licitra L. Bossi P, et al. Among authors: bergamini c. Oral Oncol. 2010 Dec;46(12):888; author reply 889-90. doi: 10.1016/j.oraloncology.2010.06.005. Epub 2010 Oct 16. Oral Oncol. 2010. PMID: 20952248 No abstract available.
Targeted therapy in head and neck cancer.
Licitra L, Bergamini C, Mirabile A, Granata R. Licitra L, et al. Among authors: bergamini c. Curr Opin Otolaryngol Head Neck Surg. 2011 Apr;19(2):132-7. doi: 10.1097/MOO.0b013e328344b668. Curr Opin Otolaryngol Head Neck Surg. 2011. PMID: 21372717 Review.
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer.
Bossi P, Orlandi E, Bergamini C, Locati LD, Granata R, Mirabile A, Parolini D, Franceschini M, Fallai C, Olmi P, Quattrone P, Potepan P, Gloghini A, Miceli R, Mattana F, Scaramellini G, Licitra L. Bossi P, et al. Among authors: bergamini c. Ann Oncol. 2011 Nov;22(11):2495-2500. doi: 10.1093/annonc/mdq783. Epub 2011 Mar 11. Ann Oncol. 2011. PMID: 21398385 Free article.
508 results